Filing Details
- Accession Number:
- 0001209191-23-010045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-16 16:11:01
- Reporting Period:
- 2023-02-14
- Accepted Time:
- 2023-02-16 16:11:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-14 | 800 | $295.79 | 53,596 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-14 | 842 | $296.85 | 52,754 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-14 | 395 | $297.97 | 52,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-14 | 2,165 | $299.08 | 50,194 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-14 | 1,888 | $300.11 | 48,306 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-14 | 308 | $301.02 | 47,998 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $295.79 (range $295.31 to $296.12).
- Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.42 to $297.37).
- Open market sales reported on this line occurred at a weighted average price of $297.97 (range $297.50 to $298.35).
- Open market sales reported on this line occurred at a weighted average price of $299.08 (range $298.71 to $299.54).
- Open market sales reported on this line occurred at a weighted average price of $300.11 (range $299.76 to $300.70).
- Open market sales reported on this line occurred at a weighted average price of $301.02 (range $300.79 to $301.22).
Billionaire Hedge Funds
